Ozempic’s unconventional origins
Behind the Money
00:00
Novonorta's Challenges and Future Prospects
This chapter discusses the challenges that Novonorta's faces heading into 2024, including the lack of sufficient supply, reluctance of payers to cover costs, and high price of drugs. It also highlights the company's efforts to address these challenges and their expectations for continued growth in sales while dealing with supply issues and staying ahead of competitors.
Transcript
Play full episode
